Paloma Partners’s Cantel Medical Corporation CMD Stock Holding History

Paloma Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,337	Closed	-$586K	–	2444
2020 Q3	$586K	Buy	+13,337	New	+$657K	0.01%	1056
2019 Q3	–	Sell	-5,798	Closed	-$468K	–	2411
2019 Q2	$468K	Buy	+5,798	New	+$408K	0.01%	1080
2018 Q3	–	Sell	-100,499	Closed	-$9.89M	–	2076
2018 Q2	$9.89M	Buy	+100,499	New	+$11.2M	0.18%	88
2017 Q4	–	Sell	-18,039	Closed	-$1.7M	–	2436
2017 Q3	$1.7M	Buy	18,039 +15,157	+526%	+$1.2M	0.02%	848
2017 Q2	$225K	Buy	+2,882	New	+$216K	﹤0.01%	1949
2016 Q4	–	Sell	-6,080	Closed	-$474K	–	2223
2016 Q3	$474K	Sell	6,080 -6,572	-52%	-$477K	0.01%	1434
2016 Q2	$870K	Buy	12,652 +5,602	+79%	+$386K	0.01%	1241
2016 Q1	$503K	Buy	+7,050	New	+$443K	0.01%	1303
2015 Q1	–	Sell	-5,696	Closed	-$247K	–	1510
2014 Q4	$247K	Buy	+5,696	New	+$233K	0.01%	938

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Paloma Partners's CMD Position: Q4 2020 in Review

Paloma Partners sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 13,337 shares — an estimated $586K sold.

Paloma Partners first reported a position in CMD in Q4 2014 and held it in 9 quarters. The position peaked at $9.89M in Q2 2018. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

Paloma Partners reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 13,337 Cantel Medical Corporation shares in Q4 2020, an estimated $586K.
Paloma Partners first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 9 quarters.
Paloma Partners's Cantel Medical Corporation position peaked at $9.89M in Q2 2018.
229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.